Extended Data Table 4 Subsequent systemic anticancer treatments by drug category

From: Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial

  1. Classified using the WHODD GLOBALB3 MAR2023 coding dictionary.
Back to article page